Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing r
Median Overall Survival (mOS) | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Figure 1 from Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. | Semantic Scholar
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Peregrine Pharmaceuticals, Inc. Drug Doubles Lung Cancer Survival in Trial | BioSpace
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology
Pancancer survival analysis of cancer hallmark genes | Scientific Reports
Overall survival rates of patients with lung cancer. Kaplan-Meier... | Download Scientific Diagram
Kaplan-Meier curves for overall survival (A) and progression-free... | Download Scientific Diagram
Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis | PLOS ONE
Cancer - Our World in Data
Overall survival and breast-cancer-specific survival curves according... | Download Scientific Diagram
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study - The Lancet Oncology
Prognostic factors in epithelial ovarian cancer: A population-based study | PLOS ONE
Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials | Journal for ImmunoTherapy of Cancer
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications
SOLO-2: Overall Survival Data on Olaparib for Relapsed, BRCA-Mutated Ovarian Cancer
Retrospective observational cohort study on innovation in oncology and progress in survival: How far have we gotten in the two decades of treating patients with advanced non-small cell lung cancer as a
Understanding Survival Analysis in Clinical Trials - Clinical Oncology
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer | NEJM
Breast Cancer Survival Rates: Prognosis by Age, Race & More
Diagnostics | Free Full-Text | Prognostic Factors Associated with 5-Year Overall Survival in Cervical Cancer Patients Treated with Radical Hysterectomy Followed by Adjuvant Concurrent Chemoradiation Therapy at a Tertiary Care Center in
Frontiers | Analysis of Survival Curves: Statistical Methods Accounting for the Presence of Long-Term Survivors
